Sobaceous adenoma of the eyelid in Muir-Torre syndrome

Archives of Ophthalmology

Volumn 123, Issue 4, 2005, Pages 562-565

  Singh, Arun D ^a   Mudhar, Hardeep Singh ^b   Bhola, Ronnie ^b   Rundle, Paul A ^b   Rennie, Ian G ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; PROTEIN MLH1; PROTEIN MSH2; TUMOR MARKER;

ADULT; ARTICLE; BASAL CELL CARCINOMA; CASE REPORT; CLINICAL FEATURE; EXCISION; EYELID; EYELID TUMOR; GENETIC PREDISPOSITION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MUIR TORRE SYNDROME; OPHTHALMOSCOPY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RARE DISEASE; RECTUM CARCINOMA; SEBACEOUS GLAND; SEBACEOUS GLAND ADENOMA; VISUAL ACUITY; ADENOCARCINOMA; ADENOMA; CHEMISTRY; GASTROINTESTINAL TUMOR; MIDDLE AGED; MULTIPLE CANCER; PATHOLOGY; SEBACEOUS GLAND TUMOR; SYNDROME;

ADENOCARCINOMA; ADENOMA; EYELID NEOPLASMS; GASTROINTESTINAL NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; SEBACEOUS GLAND NEOPLASMS; SYNDROME; TUMOR MARKERS, BIOLOGICAL;

EID: 16844383410     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.123.4.562     Document Type: Article

References (24)

1. Muir EG, Bell AJY, Barlow KA. Multiple primary carcinomas of the colon, duodenum, and larynx associated with keratoacanthomata of the face. Br J Surg. 1967;54:191-195.
2. Torre D. Multiple sebaceous tumors. Arch Dermatol. 1968;98:549-551.
3. Cohen PR, Kohn SR, Kurzrock R. Association of sebaceous gland tumors and internal malignancy: the Muir-Torre syndrome. Am J Med. 1991;90:606-613.
4. Hall NR, Williams MA, Murday VA, Newton JA, Bishop DT. Muir-Torre syndrome: a variant of the cancer family syndrome. J Med Genet. 1994;31:627-631.
5. Kruse R, Rutten A, Lamberti C, et al. Muir-Torre phenotype has a frequency of DNA mismatch-repair-gene mutations similar to that in hereditary nonpolyposis colorectal cancer families defined by the Amsterdam criteria. Am J Hum Genet. 1998;63:63-70.
6. Honchel R, Hailing KC, Schaid DJ, Pittelkow M, Thibodeau SN. Microsatellite instability in Muir-Torre syndrome. Cancer Res. 1994;54:1159-1163.
7. Poyhonen M, Niemela S, Herva R. Risk of malignancy and death in neurofibromatosis. Arch Pathol Lab Med. 1997;121:139-143.
8. Traboulsi EI, Krush AJ, Gardner EJ, et al. Prevalence and importance of pigmented ocular fundus lesions in Gardner's syndrome. N Engl J Med. 1987;316:661-667.
9. Gorlin RJ. Nevoid basal cell carcinoma syndrome. Medicine (Baltimore). 1987;66:98-113.
10. Bardenstein DS, McLean IW, Nerney J, Boatwright RS. Cowden's disease. Ophthalmology. 1988;95:1038-1041.
11. Carney JA. The Carney complex (myxomas, spotty pigmentation, endocrine overactivity, and schwannomas). Dermatol Clin. 1995;13:19-26.
12. Eter N, Klingmüller D, Höppner W, Spitznas M. Typical ocular findings in a patient with multiple endocrine neoplasia type 2b syndrome. Graefes Arch Clin Exp Ophthalmol. 2001;239:391-394.
13. Hauck RM, Manders EK. Familial syndromes with skin tumor markers. Ann Plast Surg. 1994;33:102-111.
14. Ponder BAJ. Inherited cancer syndromes. In: Carney D, Sikora K, eds. Genes and Cancer. New York, NY: John Wiley & Sons; 1990:99-106.
15. Weedon D. Skin Pathology. 2nd ed. London, England: Churchill Livingstone; 2002:873-877.
16. Burgdorf WH, Pitha J, Fahmy A. Muir-Torre syndrome: histologic spectrum of sebaceous proliferations. Am J Dermatopathol. 1986;8:202-208.
17. Propeck PA, Warner T, Scanlan KA. Sebaceous carcinoma of the breast in a patient with Muir-Torre syndrome. AJR Am J Roentgenol. 2000;174:541-542.
18. Mencia-Gutierrez E, Gutierrez-Diaz E, Santos-Briz A, Madero-Garcia S. Sebaceous gland carcinoma of the eyelid and palpebral conjunctiva in a patient with Muir-Torre syndrome. Br J Ophthalmol. 2000;84:1325-1326.
19. Jakobiec FA, Zimmerman LE, La Piana F, et al. Unusual eyelid tumors with sebaceous differentiation in the Muir-Torre syndrome: rapid clinical regrowth and frank squamous transformation after biopsy. Ophthalmology. 1988;95:1543-1548.
20. Meier-Gibbons F, Messmer E. Sebaceous gland adenoma of the palpebral conjunctiva in a patient with Muir-Torre-syndrome: a case report. Graefes Arch Clin Exp Ophthalmol. 1994;232:734-736.
21. Rustgi AK. Hereditary gastrointestinal polyposis and non-polyposis syndromes. N Engl J Med. 1994;331:1694-1700.
22. Thibodeau SN, French AJ, Roche PC, et al. Altered expression of hMSH2 and hMLH1 in tumours with microsatellite instability and genetic alterations in mismatch repair genes. Cancer Res. 1996;56:4836-4840.
23. Mathiak M, Rutten A, Mangold E, et al. Loss of DNA mismatch repair proteins in skin tumours form patients with Muir-Torre syndrome and MSH2 and MLH1 germline mutations: establishment of immunohistochemical analysis as a screening test. Am J Surg Pathol. 2002;26:338-343.
24. Machin P, Catasus L, Pons C, et al. Microsatellite instability and immunostaining for MSH2 and MLH1 in cutaneous and internal tumors from patients with the Muir-Torre syndrome. J Cutan Pathol. 2002;29:415-420.